Moderna COVID-19 vaccine Spikevax sales to reduce amid strong competition: GlobalData
GlobalData expects Spikevax vaccine market share to decline from 30 per cent in 2022 to just 16 per cent by the end of 2028
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
COVID-19 therapeutics
Clinical trials of COVID-19 vaccines and therapeutics demonstrate diverse trends: GlobalData
The upward trend for vaccine COVID-19 clinical trials is expected to continue while there will be a decrease in therapeutic…
US keen to work with Indian investigators in COVID-19 clinical trials: Dr Fauci
The partnerships between the NIH and India's DBT as well as the ICMR have helped produce important scientific and public health…
Drug makers, BMGF pledge to strive for global access to COVID-19 diagnostics, therapeutics and…
They assured that they will work towards developing innovations to fight the COVID-19 pandemic, ensuring their timely availability…